SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Lifted by Equitable Holdings Inc.

Equitable Holdings Inc. lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.9% in the second quarter, HoldingsChannel reports. The fund owned 24,138 shares of the exchange traded fund’s stock after purchasing an additional 1,549 shares during the quarter. Equitable Holdings Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,268,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of XBI. Resources Management Corp CT ADV lifted its stake in SPDR S&P Biotech ETF by 144.4% during the first quarter. Resources Management Corp CT ADV now owns 220 shares of the exchange traded fund’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. GPS Wealth Strategies Group LLC lifted its stake in SPDR S&P Biotech ETF by 197.3% during the second quarter. GPS Wealth Strategies Group LLC now owns 220 shares of the exchange traded fund’s stock valued at $30,000 after purchasing an additional 146 shares during the last quarter. Harbour Investments Inc. acquired a new stake in SPDR S&P Biotech ETF during the first quarter valued at approximately $36,000. Atlas Capital Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 328.6% during the second quarter. Atlas Capital Advisors LLC now owns 300 shares of the exchange traded fund’s stock valued at $41,000 after purchasing an additional 230 shares during the last quarter. Finally, First Horizon Corp lifted its stake in SPDR S&P Biotech ETF by 133.3% during the first quarter. First Horizon Corp now owns 350 shares of the exchange traded fund’s stock valued at $47,000 after purchasing an additional 200 shares during the last quarter.

XBI stock opened at $130.25 on Wednesday. SPDR S&P Biotech ETF has a 12 month low of $105.89 and a 12 month high of $174.79. The firm has a 50 day simple moving average of $128.08 and a 200 day simple moving average of $131.51.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: Is the QQQ ETF safe?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.